Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tovorafenib in Pediatric and Young Adult Patients Newly Diagnosed With High-Grade Glioma
NCT07206849Phase 2Not yet recruiting
- Sponsor
- Nationwide Children's Hospital
- Start
- Feb 2027
- Primary completion
- Feb 2030
- Modality
- Fragment-Derived Small Molecules, Reversible Covalent Inhibitors, Bivalent/Multivalent Binders
01
Overview
A Phase 2 trial of tovorafenib in glioma, diffuse intrinsic pontine glioma (DIPG), sponsored by Nationwide Children's Hospital. Planned start Feb 2027; status: not yet recruiting.
02
Drugs
tovorafenib
03
Conditions
gliomadiffuse intrinsic pontine glioma (DIPG)
Beyond the preview
Go deeper on NCT07206849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07206849.